✦ LIBER ✦

Efficacy of spraying l-menthol solution during endoscopic treatment of early gastric cancer: a phase III, multicenter, randomized, double-blind, placebo-controlled study

✍ Scribed by Mitsuhiro Fujishiro, Michio Kaminishi, Naoki Hiki…

Book ID: 120914603
Publisher: Springer Japan
Year: 2013
Tongue: English
Weight: 340 KB
Volume: 49
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-013-0856-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiperistaltic effect and safety of l-m

Antiperistaltic effect and safety of l-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study

✍ Naoki Hiki; Michio Kaminishi; Kenjiro Yasuda; Noriya Uedo; Hajime Honjo; Nobuyuk 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Oxcarbazepine—Efficacy and Tolerability

Oxcarbazepine—Efficacy and Tolerability During Treatment of Alcohol Withdrawal: A Double-Blind, Randomized, Placebo-Controlled Multicenter Pilot Study

✍ Dagmar Koethe; Antje Juelicher; Brit M. Nolden; Wolf-Dietrich Braunwarth; Joachi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB

Efficacy of Dysport® (Botulinum toxin ty

Efficacy of Dysport® (Botulinum toxin type A) for the treatment of cervical dystonia: A multicenter, randomized, double-blind, placebo-controlled phase III study

✍ Truong Daniel; Lew Mark; Orlova Olga 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Transdermal buprenorphine in the treatme

Transdermal buprenorphine in the treatment of chronic pain: Resultsof a phase III, multicenter, randomized, double-blind, placebo-controlled study

✍ Jürgen Sorge; Reinhard Sittl 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 935 KB

Efficacy and safety of fentanyl sublingu

Efficacy and safety of fentanyl sublingual spray for the treatment of breakthrough cancer pain: a randomized, double-blind, placebo-controlled study

✍ Rauck, Richard; Reynolds, Lowell; Geach, Jonathan; Bull, Janet; Stearns, Lisa; S 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 430 KB

Results of a multicenter placebo-control

Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma

✍ E. M. Lemmel; D. Brackertz; M. Franke; W. Gaus; P. W. Hartl; K. Machalke; H. Mie 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 660 KB

In a multicenter placebo-controlled double-blind randomized clinical study, 91 patients with rheumatoid arthritis were given 28 days' treatment with recombinant interferon-gamma (50 micrograms daily for 20 days, then 50 micrograms each second day up to day 28, given by subcutaneous injection). The a